Glasit EB 10/10mg Tablet 10s

Glasit EB 10/10mg Tablet 10s provides comprehensive lipid-lowering through complementary mechanisms. Oral administration results in rapid systemic absorption of both components.

Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, depleting intracellular cholesterol and upregulating LDL receptor expression. Concurrently, Ezetimibe selectively inhibits NPC1L1-mediated cholesterol uptake at the intestinal brush border. This synergistic approach reduces circulating LDL-C by 50-60%, substantially exceeding monotherapy results, while modestly lowering triglycerides and raising HDL-C.

Particularly beneficial for patients with genetic dyslipidaemias, established atherosclerotic cardiovascular disease, or diabetes mellitus requiring aggressive lipid target achievement. When endogenous clearance mechanisms fail due to receptor downregulation or absorption overload, Glasit EB 10/10mg Tablet 10s restores lipid homeostasis, enabling guideline-directed LDL-C goals (<70 mg/dL for very high-risk patients).

Therapeutic effects manifest within 2 weeks, with maximal LDL reduction by 4-6 weeks. Once-daily dosing aligns with steady-state pharmacokinetics. Primary hepatic metabolism minimises systemic off-target effects.

Predominantly hepatically eliminated; dose modification required for transaminitis or active liver disease. When appropriately prescribed, Glasit EB 10/10mg Tablet 10s represents evidence-based pharmacotherapy for reducing major adverse cardiovascular events in high-risk dyslipidaemia.

Primary Hypercholesterolemia

Treatment of high LDL cholesterol that persists despite diet and exercise.

Mixed Dyslipidemia

Management of elevated LDL plus high triglycerides in high-risk patients.

Heart Attack Prevention

Reducing cardiovascular events in patients with established coronary artery disease.

Stroke Risk Reduction

Lowers the risk of ischemic stroke in patients with atherosclerotic vascular disease.

Post-PCI Support

Lipid control following coronary stent placement or bypass surgery.

• Effective LDL Reduction: Atorvastatin blocks cholesterol production while Ezetimibe blocks absorption, cutting LDL by 50-60% (essential for aggressive cholesterol management).

• Reduction in Chest Pain: Primary benefit is fewer angina episodes and better exercise tolerance through plaque stabilisation.

• Plaque Regression: Combined action shrinks arterial plaque volume, restoring vessel flexibility.

• Targeted Dual Mechanism: Unlike statins alone, it adds intestinal cholesterol blocking without muscle side effects common in high-dose statins.

• Support for High-Risk Patients: Ideal for familial hypercholesterolemia or diabetes where single therapy fails LDL targets.

• Predictable 24-Hour Control: Once-daily dosing provides consistent cholesterol suppression covering all meals.

When taken as directed, Glasit EB 10/10mg Tablet 10s is generally safe. Side effects are usually rare, mild, and temporary.

Common Side Effects:

• Muscle Aches: Mild soreness or weakness, typically resolving within weeks.

• Headache: Occasional headaches during initial treatment.

• Stomach Upset: Nausea, diarrhoea, or abdominal discomfort.

Uncommon Side Effects:

• Fatigue: General tiredness unrelated to exercise.

• Liver Enzyme Elevation: Asymptomatic ALT/AST increases requiring monitoring.

• Joint Pain: Mild arthralgias in sensitive individuals.

• Serious Side Effects (Require Immediate Medical Attention):

• Rhabdomyolysis: Severe muscle breakdown with dark urine, extreme weakness.

• Severe Liver Injury: Jaundice, dark urine, severe abdominal pain.

• Allergic Reactions: Rash, face/throat swelling, breathing difficulty.

• Unexplained Muscle Pain: Persistent pain with fever or fatigue.

Glasit EB 10/10mg Tablet 10s should be taken exactly as prescribed by your physician. The standard regimen is once daily, typically taken in the evening with or without food. A common schedule is taking the dose anytime between dinner and bedtime. Importantly, consistent daily timing helps maintain steady cholesterol lowering. Tablets should be swallowed whole with water.

The mechanism of Glasit EB 10/10mg Tablet 10s is centred on its dual role as an HMG-CoA reductase inhibitor and cholesterol absorption inhibitor. After oral intake, Atorvastatin blocks the liver enzyme responsible for cholesterol production. Simultaneously, Ezetimibe binds to receptors located on intestinal cells that line your digestive tract. When these receptors are blocked, they prevent dietary cholesterol absorption; when liver production decreases, circulating LDL drops dramatically. Together, these actions slash bad cholesterol by 50-60% and ensure arteries receive protection from plaque buildup.

• The Evening Dose Rule: Take your daily dose at least 2-3 hours before bedtime to minimise any potential muscle discomfort during sleep.

• Hydration Focus: Stay well-hydrated with 2-3 litres of water daily; adequate hydration supports kidney function during statin therapy.

• Diet Focus: Follow a low-cholesterol diet (<200mg/day); your doctor may recommend specific foods to enhance cholesterol reduction.

• Muscle Check: Since this medicine can cause muscle pain, report any unexplained weakness, tenderness, or dark urine to your doctor immediately.

• Liver Tests Normal: Mild enzyme elevations are common initially but require monitoring; annual tests ensure safety.

• While Glasit EB 10/10mg Tablet 10s can be taken with or without food, your dietary choices are crucial due to the way these medications affect cholesterol metabolism. The absorption of Atorvastatin and Ezetimibe is not significantly altered by most foods, but certain substances can interfere with statin metabolism.

• Grapefruit Juice (High): Completely avoid grapefruit juice or Seville oranges, as they block statin metabolism, leading to muscle toxicity.

• High-Fat Meals (Moderate): While not contraindicated, high-fat meals may slightly delay absorption; evening timing usually overcomes this.

• Alcohol (Moderate): Limit to 1-2 drinks daily maximum; excess stresses liver function, already monitored by statins.

• Glasit EB 10/10mg Tablet 10s can interact with various medications that affect liver metabolism or muscle function. Combining these can lead to dangerous toxicity buildup.

• Fibrates (High): Gemfibrozil dramatically increases statin muscle toxicity risk; use fenofibrate with caution instead.

• Strong CYP3A4 Inhibitors (High): Avoid erythromycin, ketoconazole, protease inhibitors; they block statin breakdown, causing rhabdomyolysis.

• Cyclosporine (Moderate): Increases both drug levels; requires close monitoring and potential dose reduction.

• Warfarin (Moderate): Statins may enhance anticoagulant effect; monitor INR closely when starting therapy.

• Glasit EB 10/10mg Tablet 10s must be used with extreme caution in patients with specific underlying health conditions. Because the medications lower cholesterol aggressively, they can worsen conditions characterised by muscle or liver vulnerability.

• Active Liver Disease (High): Contraindicated in acute liver disease; requires baseline and periodic liver enzyme monitoring.

• Muscle Disorders (High): Patients with a history of myopathy or rhabdomyolysis face increased breakdown risk; baseline CK levels are recommended.

• Hypothyroidism (Moderate): Uncontrolled thyroid slows statin metabolism, increasing side effect risk; optimise thyroid first.

• Kidney Disease (Moderate): Ezetimibe is safe, but statins require monitoring in severe impairment to prevent accumulation.

If you miss a dose, take it as soon as you remember, unless it's close to your next scheduled dose. If your next dose is due within 12 hours, skip the missed dose entirely. Never "double up" on doses to compensate for a missed one. Taking too much medication at once can cause muscle pain or liver strain, but consistent daily use is essential for maintaining cholesterol reduction and heart protection.